Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1609558, author = {Kozlová, Veronika and Ledererová, Aneta and Mančíková, Veronika and Mayer, Jiří and Pospíšilová, Šárka and Doubek, Michael and Šmída, Michal}, booktitle = {XVIII. International Workshop on CLL, Edinburgh, Skotsko}, keywords = {CD20; CLL cells}, language = {eng}, title = {Elucidation of factors enhancing the expression of CD20 and thereby efficiency of CD20 monoclonal antibodies through epigenetic drug screening of resistant CLL cells}, url = {https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1732667}, year = {2020} }
TY - CONF ID - 1609558 AU - Kozlová, Veronika - Ledererová, Aneta - Mančíková, Veronika - Mayer, Jiří - Pospíšilová, Šárka - Doubek, Michael - Šmída, Michal PY - 2020 TI - Elucidation of factors enhancing the expression of CD20 and thereby efficiency of CD20 monoclonal antibodies through epigenetic drug screening of resistant CLL cells KW - CD20 KW - CLL cells UR - https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1732667 N2 - In spite of recent advancements in the therapy of B-cell malignancies, CD20-targeted monoclonal antibodies (mAbs) still remain the key part of therapy in clinical practice. Furthermore, the combination of CD20 mAbs with targeted agents is being tested in clinical trials. Therefore, the knowledge of CD20 regulation remains a critical issue to address. Despite using CD20 as the prime target of therapy for decades now, the information about its function and molecular mechanisms remains to be scarce. Since low expression of CD20 on the surface of malignant B cells represents an important basis for CD20 antibody therapy failure, the idea of modulating CD20 levels seems an appealing strategy to enhance the success rate of CD20 immunotherapy ER -
KOZLOVÁ, Veronika, Aneta LEDEREROVÁ, Veronika MANČÍKOVÁ, Jiří MAYER, Šárka POSPÍŠILOVÁ, Michael DOUBEK a Michal ŠMÍDA. Elucidation of factors enhancing the expression of CD20 and thereby efficiency of CD20 monoclonal antibodies through epigenetic drug screening of resistant CLL cells. In \textit{XVIII. International Workshop on CLL, Edinburgh, Skotsko}. 2020. ISSN~1042-8194.
|